VTGN logo

VistaGen Therapeutics (VTGN) CAPEX

Annual CAPEX

$61.00 K
-$151.00 K-71.23%

March 31, 2024

Summary

Performance

1-Year Change

-71.23%

3-Year Change

-77.85%

5-Year Change

-64.94%

15-Year Change

-74.49%

VTGN CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.89%
VTGN annual capital expenditures is higher than 9.89% of companies in Healthcare sector

High & Low

All-time High

$275.40 K
VTGN annual capital expenditures is currently -77.85% below its historical high of $275.40 thousand

3-Year Low

$61.00 K
VTGN annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
VTGN previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

N/A
VTGN next annual earnings announcement has not yet been scheduled

OtherVTGNcash flowmetrics:

Annual FCF

-$25.87 M
VTGN annual free cash flow is -$25.87 million

Annual CFO

-$25.81 M
VTGN annual cash flow from operations is -$25.81 million

Annual CFI

-$61.00 K
VTGN annual cash flow from investing activities is -$61.00 thousand

Annual CFF

$128.40 M
VTGN annual cash flow from financing activities is $128.40 million

Quarterly CAPEX

$61.00 K
+$19.00 K+45.24%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

VTGN Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.47%
VTGN quarterly capital expenditures is higher than 25.47% of companies in Healthcare sector

High & Low

All-time High

$229.20 K
VTGN quarterly capital expenditures is currently -73.39% below its historical high of $229.20 thousand

3-Year Low

-$100.00

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VTGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
VTGN next earnings announcement is scheduled for Feb 13, 2025

OtherVTGNcash flowmetrics:

Quarterly FCF

-$10.95 M
VTGN quarterly free cash flow is -$10.95 million

Quarterly CFO

-$10.89 M
VTGN quarterly cash flow from operations is -$10.89 million

Quarterly CFI

-$7.79 M
VTGN quarterly cash flow from investing activities is -$7.79 million

Quarterly CFF

$0.00
VTGN quarterly cash flow from financing activities is $0.00

TTM CAPEX

$164.00 K
+$61.00 K+59.22%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

VTGN TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

14.56%
VTGN TTM capital expenditures is higher than 14.56% of companies in Healthcare sector

High & Low

All-time High

$425.30 K
VTGN TTM capital expenditures is currently -61.44% below its historical high of $425.30 thousand

3-Year Low

$32.30 K
VTGN TTM capital expenditures is currently +407.74% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VTGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
VTGN next earnings announcement is scheduled for Feb 13, 2025

OtherVTGNcash flowmetrics:

TTM FCF

-$33.65 M
VTGN TTM free cash flow is -$33.65 million

TTM CFO

-$33.49 M
VTGN TTM cash flow from operations is -$33.49 million

TTM CFI

-$13.31 M
VTGN TTM cash flow from investing activities is -$13.31 million

TTM CFF

$93.44 M
VTGN TTM cash flow from financing activities is $93.44 million

VTGN CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-71.2%0.0%0.0%
3 y3 years-77.8%0.0%0.0%
5 y5 years-64.9%0.0%0.0%

VTGN CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-77.8%at low-65.2%>+9999.0%-27.4%+407.7%
5 y5-year-77.8%at low-65.2%>+9999.0%-61.4%+407.7%
alltimeall time-77.8%+3712.5%-73.4%+353.1%-61.4%>+9999.0%

VistaGen Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$61.00 K(+45.2%)
$164.00 K(+59.2%)
Jun 2024
-
$42.00 K(+46.3%)
$103.00 K(+68.9%)
Mar 2024
$61.00 K(-71.2%)
$28.70 K(-11.1%)
$61.00 K(+88.9%)
Dec 2023
-
$32.30 K(>+9900.0%)
$32.30 K(-84.8%)
Mar 2023
$212.00 K(+5.8%)
$0.00(-100.0%)
$212.00 K(-0.0%)
Dec 2022
-
$12.50 K(-48.8%)
$212.10 K(+6.3%)
Sep 2022
-
$24.40 K(-86.1%)
$199.50 K(-11.6%)
Jun 2022
-
$175.10 K(>+9900.0%)
$225.60 K(+12.6%)
Mar 2022
$200.40 K(-27.2%)
$100.00(-200.0%)
$200.40 K(-11.2%)
Dec 2021
-
-$100.00(-100.2%)
$225.80 K(-40.1%)
Sep 2021
-
$50.50 K(-66.3%)
$377.00 K(-11.4%)
Jun 2021
-
$149.90 K(+487.8%)
$425.30 K(+54.4%)
Mar 2021
$275.40 K(+58.3%)
$25.50 K(-83.1%)
$275.40 K(+10.2%)
Dec 2020
-
$151.10 K(+52.9%)
$249.90 K(+152.9%)
Sep 2020
-
$98.80 K(+2252.4%)
$98.80 K(-43.2%)
Mar 2019
$174.00 K
$4200.00(>+9900.0%)
$174.00 K(+2.5%)
Dec 2018
-
$0.00(-100.0%)
$169.80 K(0.0%)
Sep 2018
-
$134.40 K(+279.7%)
$169.80 K(+358.9%)
DateAnnualQuarterlyTTM
Jun 2018
-
$35.40 K(>+9900.0%)
$37.00 K(+2212.5%)
Mar 2018
$1600.00(-99.3%)
$0.00(0.0%)
$1600.00(-99.3%)
Dec 2017
-
$0.00(-100.0%)
$230.80 K(-0.9%)
Sep 2017
-
$1600.00(-99.3%)
$233.00 K(-2.6%)
Mar 2017
$239.10 K(+809.1%)
$229.20 K(>+9900.0%)
$239.10 K(+656.6%)
Dec 2016
-
$2200.00(-61.4%)
$31.60 K(-7.1%)
Sep 2016
-
$5700.00(+185.0%)
$34.00 K(+20.1%)
Jun 2016
-
$2000.00(-90.8%)
$28.30 K(+7.6%)
Mar 2016
$26.30 K(+174.0%)
$21.70 K(+371.7%)
$26.30 K(+471.7%)
Dec 2015
-
$4600.00(>+9900.0%)
$4600.00(-52.1%)
Mar 2014
$9600.00(-92.9%)
$0.00(-100.0%)
$9600.00(-30.9%)
Dec 2013
-
-$24.10 K(-200.0%)
$13.90 K(-91.8%)
Sep 2013
-
$24.10 K(+151.0%)
$169.10 K(+16.6%)
Jun 2013
-
$9600.00(+123.3%)
$145.00 K(+7.1%)
Mar 2013
$135.40 K(+317.9%)
$4300.00(-96.7%)
$135.40 K(-9.8%)
Dec 2012
-
$131.10 K(+590.0%)
$150.10 K(+363.3%)
Mar 2012
$32.40 K
$19.00 K(+239.3%)
$32.40 K(+141.8%)
Dec 2011
-
$5600.00(-28.2%)
$13.40 K(+71.8%)
Sep 2011
-
$7800.00
$7800.00

FAQ

  • What is VistaGen Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for VistaGen Therapeutics?
  • What is VistaGen Therapeutics annual CAPEX year-on-year change?
  • What is VistaGen Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for VistaGen Therapeutics?
  • What is VistaGen Therapeutics quarterly CAPEX year-on-year change?
  • What is VistaGen Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for VistaGen Therapeutics?
  • What is VistaGen Therapeutics TTM CAPEX year-on-year change?

What is VistaGen Therapeutics annual capital expenditures?

The current annual CAPEX of VTGN is $61.00 K

What is the all time high annual CAPEX for VistaGen Therapeutics?

VistaGen Therapeutics all-time high annual capital expenditures is $275.40 K

What is VistaGen Therapeutics annual CAPEX year-on-year change?

Over the past year, VTGN annual capital expenditures has changed by -$151.00 K (-71.23%)

What is VistaGen Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of VTGN is $61.00 K

What is the all time high quarterly CAPEX for VistaGen Therapeutics?

VistaGen Therapeutics all-time high quarterly capital expenditures is $229.20 K

What is VistaGen Therapeutics quarterly CAPEX year-on-year change?

Over the past year, VTGN quarterly capital expenditures has changed by $0.00 (0.00%)

What is VistaGen Therapeutics TTM capital expenditures?

The current TTM CAPEX of VTGN is $164.00 K

What is the all time high TTM CAPEX for VistaGen Therapeutics?

VistaGen Therapeutics all-time high TTM capital expenditures is $425.30 K

What is VistaGen Therapeutics TTM CAPEX year-on-year change?

Over the past year, VTGN TTM capital expenditures has changed by $0.00 (0.00%)